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Abstract 
The authors report on a fluorometric method for the rapid detection of BRCA1, CFRT and 
MRP3 gene mutations. These are associated with breast cancer, cystic fibrosis and 
autoimmune hepatitis diseases, respectively. Carbon nanodots with blue fluorescence (with 
excitation/emission maxima at 340/440 nm) were synthesized and characterized, and their 
interactions with DNA were investigated. Changes in the fluorescence intensity following 
interaction with ssDNA and dsDNA were used for specific DNA sequence of BRCA1, CFRT 
and MRP3 genes detection. The response to DNAs is linear up to 200 nM and the detection 
limit is 270 pM. The assay selectivity allows the detection of single gene mutations. Under 
optimum conditions, the assay can rapidly discriminate between wild type and mutated 
samples.  
Keywords: rapid assay, Cancer, Fluorescent Carbon nanodots, DNA sensing, Mutations, 
Genetic diseases, Fluorescent assay. 
1. Introduction
Common diagnostic methods of human genetic diseases are based on the detection of gene 
mutations. Genetic predisposition to a disease may derive from abnormal gene expressions 
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or from gene mutations. The usual way to detect mutations is DNA sequencing, by the classic 
Sanger method, but it is frequently a laborious task depending on the size of the gene and the 
numerous possible mutations. Hence, the development of rapid assays for the detection of 
specific DNA sequences or the presence of DNA mutations, based on the principle of 
complementary base pairing, will greatly reduce the assay time and simplify the analytical 
protocols. The idea is to provide assays that can perform potent molecular scans capable of 
identifying and analyzing changes in gene expression. This definitely will help provide less 
aggressive and effective therapeutic solutions and increase the chances of survival [1-6], in 
particular in less developed countries with limited laboratory capacities. In this sense, any 
cost-effective, accurate, and sensitive fluorescence assay for rapid gene mutation detection 
would represent an important improvement to the traditional DNA sequencing methods and 
an extremely valuable fast screening method. Hence, fluorescence-based systems involving 
different nanomaterials have been widely employed for DNA sequences detection due to the 
advantages of them including sensitivity, specificity and cost-effectiveness [7, 8]. In this 
sense, carbon nanodots (CNDs) have attracted great interest, being employed as fluorescent 
probes for detection of biological and environmental analytes [9, 10]. 
In a previous work [11] we employed carbon nanodots as a conductive nanomaterial to 
nanostructure screen-printed gold electrodes. It is well known that nanostructuring of the 
working electrode through the application of nano-sized modifiers offers attractive new 
features. The nanostructured electrode allows the development of an electrochemical DNA 
biosensor without the need of using modified DNA probes. In the present work, we wanted 
to go a step forward and we have taken advantage of the fluorescent properties of CNDs. 
First, we have synthetized a new type of CNDs using precursors specifically designed to 
obtain CNDs with a high quantum yield. Then, we have used these CNDs as labels of the 
hybridization detection to develop a rapid assay for detection of gene mutations associated 
with human diseases. Although based on CNDs, both strategies are completely different. 
Moreover, in the present work, as far as we know, is the first time that fluorescent CNDs are 
employed to detect specific DNA sequences and the presence of mutations, obviating in this 
way the need of labelling the probe or the target previously.  We demonstrate the utility of 
the method by applying it to the detection of specific gene mutations associated to three 
important human diseases: 1) breast cancer gene (BRCA1) which helps suppress cancerous 
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cells [12]; 2) cystic fibrosis transmembrane regulator gene (CFTR) and 3) multidrug 
resistance protein (MRP3) gene, associated to liver diseases, such as autoimmune hepatitis. 
2. Experimental
2.1. Chemicals 
Citric acid 99 %, ethylene diamine, sodium phosphate and sodium chloride and all other 
chemicals used in this work were reagent grade quality, and were obtained from Sigma-
Aldrich Co. (https://www.sigmaaldrich.com), Water was purified with a Millipore Milli-Q-
System (18.2 MΩ cm) and all solutions were prepared just prior to use. Double stranded calf 
thymus DNA (dsDNA) was also purchased from Sigma-Aldrich Co. dsDNA stock solutions 
(1.0 mg.mL-1) were prepared in 0.1 M phosphate buffer (PB) pH 7.0. The DNA solutions UV 
absorbance ratio (A260/A280) was about 1.9, suggesting that the DNA was free of protein [13]. 
Using a molar absorptivity of 6600 M-1cm-1 at 260 nm [14] the concentration in base pairs 
(bp) of DNA was determined. Single-stranded calf thymus DNA (ssDNA) was obtained by 
boiling in water capped vials containing dsDNA in 0.1 M PB pH 7.0 for 30 minutes. To 
prevent spontaneous renaturation, this reaction was subsequently quenched in an ice-bath. 
Custom-made synthetic oligonucleotides, 110-mer, from sequences of BRCA1, CFTR and 
MRP3 genes were supplied by Sigma-Aldrich Co. (see Table S1).  
2.2. Experimental techniques 
Fourier Transform Infrared (FTIR) spectra of pellets of KBr powder and the samples were 
recorded in transmission on a Bruker IFS60v Fourier-transform infrared spectrometer. 
Transmission electron microscopy (TEM) measurements were performed on a FEG S/TEM 
(Talos F200X, FEI) electron microscope. UV-vis absorption spectra were recorded on a 
double beam PharmaSpec UV-1700 series Shimadzu spectrophotometer operating from 200 
nm to 800 nm. Fluorescence emission spectroscopy was carried out on a Cary Eclipse Varian 
spectrofluorimeter. Dynamic light scattering (DLS) and Zeta potential measurements were 
determined at 25 ºC using a Zetasizer Nano ZS instrument (Malvern Instrument Ltd., 
Grovewood, Worcestershire, UK). Elemental Analysis measurements were carried out using 
a LECO CHNS-932 system. Melting curves were performed on a UV-Visible 
spectrophotometer with a thermostated bath in conjunction with the spectrophotometer to 
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control the cuvette temperature during the measurements. The temperature inside the cuvette 
was determined with a platinum thermocouple. Fluorescence images were observed in an 
inverted microscope Axiovert200 (Zeiss) coupled to a CCD (charged-coupled device) 
monochrome camera and processed with Fiji-Image software. The source of illumination was 
a SPECTRA-X (LUMENCOR) and a 10X/0.45 Plan/Apochromat Ph 1 objective was used 
for detection. The excitation filter used was DAPI (395/25) and the emission was registered 
with a DAPI (432/36) filter. 
Atomic Force Microscope (AFM) techniques were used in dynamic mode using a Nanotec 
Electronica system operating at room temperature in ambient conditions. The images were 
processed using WSxM [15]. For AFM measurements, commercial Olympus Si/N 
cantilevers were used with a nominal force constant of 0.75 N/m.  
XPS (X ray Photoelectron Spectroscopy) measurements were performed under Ultra High 
Vacuum conditions (UHV, with a base pressure of 5×10-10 mbar), using a monochromatic Al 
Kα line as exciting photon source for core level analysis (hν = 1486.7 eV). The emitted 
photoelectrons were collected in a hemispherical energy analyzer (SPHERA-U7, pass energy 
set to 20 eV for the XPS measurements to have a resolution of 0.6 eV) and to compensate 
the built up charge on the sample surface it was necessary the use of a Flood Gun (FG-500, 
Specs), with low energy electrons of 3 eV and 40 μA. Binding energy correction used was Si 
2p3/2, 99.3 eV. 
2.3. Procedures 
Procedures for Elemental Analysis, Fourier Transform Infrared (FTIR) analysis, Atomic 
Force Microscopy (AFM), XPS analysis, UV-visible absorption and fluorescence emission 
are described in detail in Electronic Supplementary Information (ESM). 
2.4. DNA sensing 
10 µL of a 100 µM solution containing the corresponding oligonucleotide were mixed with 
10 µL of a 20 µM CNDs solution and were brought to a final volume of 100 µL with 0.1M 
PB pH 7.0. The mixture was allowed to react for 2 h. Fluorescence of this solution was 
monitored at 440 nm with an excitation λ = 340 nm at room temperature.  Hybridization with 





CNDs mixture, bringing it to a final volume of 100 µL with 0.1 M PB pH 7.0 + 0.4 M NaCl 
and heating it for 1 h at 40 ºC. After cooling to room temperature, fluorescence was monitored 
at the same excitation wavelength. 
 
3. Results and discussion 
3.1. Choice of Materials. 
Great efforts have been focused on the synthesis of non-toxic fluorescent nanomaterials as 
an alternative to the well-known semiconductor quantum dots containing toxic heavy metals. 
Carbon nanodots (CNDs) are recently discovered C-based nanomaterials that comprise 
discrete, quasispherical nanoparticles with sizes below 10 nm [9, 16-21]. These C 
nanomaterials can be produced easily from a wide range of raw materials by methods that do 
not require scarce elements or stringent, intricate, tedious, costly, or inefficient preparation 
steps [20, 22]. Moreover, they present robust chemical inertness, high solubility in aqueous 
media and, similar to quantum dots (QDs), good photostability [16, 23, 24], but they excel 
by their high biocompatibility, due to the absence of toxic metal ions. They can also be 
excellent sensing platforms for DNA, a topic still insufficiently explored. The DNA sensing 
method would be based on changes in CNDs fluorescence intensity after interaction with 
single or double-stranded DNA. Compared to other fluorescent probes used for gene 
mutation detection, such as Ag nanoclusters [25] or a iridium (III) based complex  [26], 
CNDs present robust chemical inertness, high solubility in aqueous media, high 
biocompatibility, due to the absence of toxic metal ions and can be produced easily from a 
wide range of raw materials. 
 
3.2. Synthesis and characterization of Carbon Nanodots (CNDs) 
We have synthetized highly fluorescent CNDs by using citric acid and ethylenediamine as 
precursors by a hydrothermal method [27] as described in the Electronic Supplementary 
Information (ESM) and depicted in Figure S1. The obtained CNDs were characterized by 
different techniques. From TEM (Figure S1) we concluded that CNDs reveal a spherical 
morphology with diameters distributed in a narrow range (2-6 nm) and an average value of 
4.1 ± 0.3 nm. FFT analysis determined a spacing of planes (Figure 1B and C) of 2.1 Å, which 
is characteristic of the CNDs (100) plane. From AFM measurements (Electronic 
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Supplementary Information Figure S2) a homogeneous distribution of CNDs is observed. 
From the histogram and profile of the magnified image (Electronic Supplementary 
Information Figure S2 C and D) an average height of 5.5 ± 1.1 nm and the large extent in 
size in the xy- direction can be explained by the presence of aggregates. Elemental analysis 
indicates that CNDs contain: 40.5% C, 4.8% N and 7.2% H. 
XPS was found to be useful in terms of deriving structural information for CNDs. The 
contributions stemming from the core levels of C1s, N1s and O1s were noted. Deconvolution 
of the C1s core-level region of CNDs points to three species with binding energies of 286.0 
(C-H and C-C), 287.84 (C-NH and C-OH) and 289.6 eV (C=O, N-C=O, O=C-OH) 
(Electronic Supplementary Information Figure S3). The fit of N1s line of CNDs points to 
two species with binding energies of 402.6 (C-N) and 401.2 eV (O=C-NH). From XPS, an 
elemental composition of 61.2% C, 10.5% N, 28.3% O was derived. The C/N ratio suggests 
a slight surface enrichment of N. 
FTIR spectroscopy was also used to investigate the functional groups of the synthesized 
CNDs. FTIR spectrum (Figure 1A) exhibits the characteristic stretching band of hydroxide 
at 3417 cm-1 besides stretching vibrations of C=O at 1711 cm-1 and the –N-H stretching peak 
at 1621 cm-1. Bands at 1366 cm-1 and 1189 cm-1 are assigned to the stretching vibrations of 
C-H [27], confirming the results obtained about the functional groups of the CNDs by XPS.
The UV-vis absorption spectrum in water (Figure 1B) shows a broad peak around 343 nm,
ascribed to n-π* transitions of C=O bonds [28]. The fluorescence spectrum when excited at
340 nm shows an emission band with a peak at 440 nm. By changing the excitation
wavelength from 320 to 400 nm (∆λex = 80 nm), the emission maximum only decreases in
intensity as λex moves away from the absorption maximum but does not shift its position.
The full width at half maximum obtained was 80 ± 2 nm confirming a homogeneous
ensemble of CNDs. In all further experiments, excitation and emission wavelengths of 340
and 440 nm, respectively, were used.
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Figure 1. A) FTIR spectrum of the synthesized CNDs. B) Absorbance and Fluorescence 
emission spectra of a 2.0 µM CNDs in water. Fluorescence emission spectra at different 
excitation wavelengths: (a) 320 nm, (b) 340 nm, (c) 360 nm, (d) 380 nm and (e) 400 nm. 
The CNDs were stable over at least 4 months with only minor changes in the fluorescence 
spectral profiles (data not shown). This greatly aids in their commercial use for different 
applications such as (bio)sensing or bioimaging. The CNDs quantum yield was calculated to 
be 30%. 
The pH study demonstrates that while the absorption does not change upon pH variation, 
emission intensities decrease in a solution of high or low pH, but remain constant in a solution 
of pH 5-8 (Electronic Supplementary Information, Figure S4). Hence, the fluorescence of the 
nanomaterial does not change appreciably within the physiological medium and therefore 
allows sensing of other factors. In particular, we used this for DNA sensing. 
3.2. CNDs-DNA interaction 
In order to analyze the interaction of CNDs with DNA, the melting temperature Tm in the 
absence and in the presence of CNDs was compared (Electronic Supplementary Information, 
Figure S5). In the presence of CNDs, Tm exhibits an increase of 12 ± 2 ºC. The Tm serves as 
a simple although powerful tool for determination of the helix stability after interaction with 
a molecule [29]. Such a study is able to provide insight into the conformational changes of 
DNA in presence of an interacting compound and also information about the interaction 















strength. When a given molecule interacts strongly with dsDNA, the stability of the double-
helix improves, and as a result, the melting temperature Tm increases by about 5-8 ºC [29]. 
No interaction causes no obvious increase in Tm [30]. Hence, our result is consistent with a 
strong interaction. 
DLS, Zeta potential and FTIR were used to assess the interaction. A detailed description of 
the procedures followed in these studies is provided in the Experimental Section. Particle 
sizes determined by DLS of dsDNA-CNDs nanohybrid and dsDNA were 1264 and 514.8 
nm, respectively. The increase in the size is concordant with the formation of aggregates. 
Such aggregates are also revealed by TEM (Electronic Supplementary Information Figure 
S6) and phosphorus from the DNA is identified by EDX. The Zeta potential was found to be 
-40.0 mV in both cases, which agrees well with the presence of phosphate groups in the DNA 
backbone that remain unaffected after interaction with CNDs. The FTIR spectrum of the 
nanohybrid shows only the characteristic bands of both the DNA and CNDs (Electronic 
Supplementary Information, Figure S7). This result suggests that the interaction between 
CNDs and DNA is due to H-bonding and π-π interactions.  
 
Fluorescence microscopy confirms the interaction of CNDs with DNA. Figure 2 shows the 
optical and fluorescence micrographs (obtained with excitation from 375 to 420 nm and 
emission from 396 to 468 nm) of dsDNA, ssDNA-CNDs, dsDNA-CNDs and CNDs samples. 
As can be observed, dsDNA-CNDs nanohybrid (G) shows fluorescence from CNDs, since 
DNA by itself does not present fluorescence under the experimental conditions employed 
(see control image (E)). On the contrary, CNDs aggregates strongly fluoresce (H). The 
micrograph of ssDNA-CNDs sample (F) presents much lower fluorescence than the one of 
dsDNA-CNDs (G). These results suggest that CNDs interact preferably with dsDNA, 
probably because in this case besides to the H-bonding and π-π interactions, CNDs can bind 








Figure 2. Optical micrographs (top line) and fluorescence micrographs (bottom line) of 
dsDNA (A, E), ssDNA-CNDs (B, F) or dsDNA-CNDs (C, G) nanohybrid samples and CNDs 
(D, H).  
 
We next investigated whether the fluorescence of CNDs depends on the presence of DNA in 
solution, which is important for CNDs to be used as DNA sensing platforms. Figure 3A 
shows the fluorescence spectra of CNDs in the absence and in the presence of increasing 
amounts of dsDNA. Excitation at 340 nm, in the absence of dsDNA, results in the 
characteristic fluorescence emission band at 440 nm. The addition of dsDNA gives rise to a 
significant gradual increase of the emission intensity with no evident shift in the emission 
maximum. The quantum yield increased from 30 % to 60 % at 5 µM dsDNA. The interaction 
mode, however, is not fully established and work is in progress to elucidate it. Most likely, 
as it happens with some molecules [31], upon noncovalent binding of CNDs to DNA the non-
radiative decay is less efficient, resulting in fluorescent enhancement. CNDs bounds to the 
DNA along the backbone by H-bonding and π–π interactions. The binding constant (Kb) was 
calculated to be 1.7±0.3 x 104 M-1. This value is similar to those reported for some 










As can be seen in Figure 3B, CNDs fluorescence is much less affected by the presence of 
ssDNA in solution, confirming that this nanomaterial interacts to a different extent with ds 
and ssDNA. In the case of the former there is a new component in the interaction due to the 
insertion of CNDs in the major grooves. 
Iodide is a well-known quencher for many fluorophores due to enhancement of intersystem 
crossing. The quenching effect can be used to determine whether the fluorophores are 
exposed to KI [33]. In our case, the presence of 5 mM iodide causes only a small decrease in 
the CNDs fluorescence (Electronic Supplementary Information, Figure S8). This suggests 
that the main fluorescence emission seems to come from fluorophores inside the CNDs and, 
therefore, iodide cannot reach them. In presence of DNA, the fluorescence is even less 
affected by the iodide. This is probably due to the Coulomb repulsion between iodide and 
negatively charged DNA backbone phosphates. 
 
3.3. DNA sensing 
Fluorescence spectroscopy and microscopy studies confirmed that, as some small molecules, 
CNDs interact to a different extent with dsDNA and ssDNA. We therefore explored if it can 
be employed for DNA sensing by analyzing a 100-mer synthetic sequence of BRCA1 gene. 
The method is based on changes in the fluorescence of the capture DNA probe (a sequence 
fully complementary to the target DNA sequence)-CNDs nanohybrid after hybridization with 
the target DNA. 
Figure 3C shows that the fluorescence of CNDs practically does not change after incubation 
with the DNA capture probe, in order to form the DNA probe-CNDs nanohybrid. However, 
after hybridization of the nanohybrid with the target (a sequence of BRCA1 totally 
complementary to the capture probe) a significant enhancement in the emission is observed, 
while a very small change is noted for a non-complementary sequence used as control. The 
fluorescence emission shows excellent correlation with the amount of the target sequence up 
to 200 nM (Figure 3D) and a reproducibility of 95 %. The detection limit was calculated as 
270 pM (according to the 3 x Sb. m-1 criteria, where Sb corresponds to the standard deviation 
(n = 6) for measurements made with non-target DNA and m is the slope of the calibration 





reported in the literature for gene mutation detection using similar nanomaterial-based 
luminescent methods (see Electronic Supplementary Information Table S2). 
 
 
Figure 3. Emission spectra of   2.0 µM CNDs in 0.1 M PB pH 7.0, in absence (black curve) 
and presence (colored curves) of dsDNA (A) and ssDNA (B). Fluorescence spectra of CNDs 
before (green curve) and after incubation with the DNA capture probe (red curve) and after 
addition of the target, a sequence of BRCA1 totally complementary to the capture probe 
(black curve) or a non-complementary sequence (blue curve) (C). Fluorescence spectra of 
DNAprobe-CNDs nanohybrid after hybridization with increasing concentrations of the 
BRCA1 gene sequence (D). Inset: Calibration plot constructed with the DNA assay of the 
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3.4. Gene mutation detection 
The selectivity of the assay was evaluated by detecting partially complementary sequences 
based on gene mutations associated with different human diseases. As is depicted in the 
Scheme of Figure 4, the mutation detection relies on the formation of the nanohybrid between 
the corresponding DNA capture probe and CNDs and the comparison between the signals 
(fluorescence) obtained before and after hybridization with the totally complementary Wild 
Type sequence (WT) or the sequence carrying the mutation (MUT). We have analyzed 
mutations consisting on a single mismatch from BRCA1 and MRP3 gene associated to breast 
cancer, and autoimmune hepatitis, respectively; and one consisting on three-base deletion 
from CFTR gene associated to cystic fibrosis (corresponding sequences are summarized in 
Electronic Supplementary Information, Table S1). Figure 4 A, B and C show that the native 
fluorescence of the CNDs is only slightly affected after their incubation with the different 
capture DNA probes to form the corresponding DNA probe-CNDs nanohybrid. However, 
after hybridization of each DNA probe-CNDs nanohybrid with its WT sequence the 
fluorescence emission increases from 50 a.u. to above 75 a.u (with a maximum error of 1.8 
a.u). Hybridization with the MUT sequence gives rise to a lower enhancement of around 10
a.u. (with a maximum error of 1.5 a.u) and with a fully non-complementary sequence causes
no effect. Given the small error associated to each measurement, we can conclude that the
method can clearly discriminate between WT and MUT sequences allowing the detection of
the different gene mutations as is presented in Figure 4D. Moreover, it is worth to note that
the assay is sensitive to the grade of non-complementarity of the target sequence. In the case
of CFTR gene, the difference in the response between WT and MUT is higher than in the
other cases. In this case, the mutation relies on a three-base deletion causing the loss of a
phenylalanine residue. However, in the case of MRP3 or BRCA1 the mutation consists in a
single nucleotide polymorphism (SNP).
We anticipate the assay will find broad application to the identification of specific DNA
sequences and gene alterations. Although as a prove of concept we have demonstrated the
applicability of the assay on synthetic samples, work is in progress employing clinical
samples. The limitation in this case consists on the genomic DNA must be previously








Figure 4. Scheme followed for gene mutation detection. Bar diagrams of CNDs fluorescence 
emission before (CNDs), after interaction with the probe (PROBE) and after hybridization 
with: fully complementary (WT), mutated (MUT) or non-complementary (NC) sequences 
from BRCA1 (A), CFTR (B) and MRP3 (C) gene associated to breast cancer, cystic fibrosis 
and autoimmune hepatitis, respectively. Summary plot of the signals obtained for all the 
samples measured (D).  
 

























































In summary, for the first time we have employed the interaction of carbon nanodots (CNDs) 
and DNA to develop a novel and effective assay for the rapid detection of gene mutations. 
Fluorescent CNDs were synthesized by simple hydrothermal carbonization of 
ethylendiamine and citric acid. Different techniques confirm that the synthesized CNDs 
interact to a different extent with dsDNA and ssDNA, resulting in different fluorescent 
response. Hence, they can be employed as a rapid and label-free assay for detection of not 
only the hybridization event and DNA sensing, but also for gene mutation detection. 
Although three genes were used as the triggering target for the assay demonstration, our 
system in principle can be extended to the detection of other genes.  These applications can 
be of great interest for faster assessment, better management and improved treatment of 
cancer and other important diseases. Compared to other methods reported for the detection 
of gene mutation, our method is highly simple and rapid, and uses unmodified 
oligonucleotides, thus avoiding the relatively high cost for covalent labeling, like the methods 
that use fluorescent metal-based complexes, but the synthesis of CNDs is easy. They can be 
synthetized from very common row and low-cost materials. The method has been applied to 
gene mutations consisting on a single mismatch oligonucleotide or a deletion, but one would 
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